2012-11-14T12:45:06-08:00 2011-12-31 Kimerling & Wisdom LLC 29 Broadway 1412 New York NY 100063267 990 2011-01-01 522275294 THE SARCOMA FOUNDATION OF AMERICA INC SARC 3012538687 9899 MAIN STREET SUITE 204 DAMASCUS MD 20872 MARK THORNTON MD PhD 2012-11-14 true Ross Wisdom CPA 2129860892 2011 2016-02-24 21:20:13Z 2270866 false false X www.curesarcoma.org X 2001 MD PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. 14 14 8 50 0 1365250 1365483 0 36965 40549 628 25129 1402843 1431161 307500 598321 0 335239 427842 116352 147348 330741 285048 423907 1044139 1597418 358704 -166257 2016438 2014825 50425 251877 1966013 1762948 PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. false false 1070434 598321 1903072 PUBLIC AWARENESS, ADVOCACY AND MEDICAL RESEARCH FUNDING FOR THE DEVELOPMENT OF NOVEL THERAPIES AGAINST SARCOMA. 1070434 true true false true false false false false false false true true false false true false true false false false true true false true true false false true false false false false false false false false false false false false false false false false false false false false false false false true 13 0 true 8 true false false false false false false true true true true false 0 false false false false false false false false false false false X 14 14 true false false false false false false true true false false false true true true true true true true true false false WI WA VA SC PA OR NY NJ NC MN MI MD MA KY IL GA FL CT CA X X ORGANIZATION 3012538687 9899 MAIN STREET SUITE 204 DAMASCUS MD 20872 MARIANNE BOULDIN 1.00 X 0 0 0 ALEXANDRA GILLESPIE 1.00 X 0 0 0 RITA SAVERINO ROMEO 1.00 X 0 0 0 CHRIS CONNERY 1.00 X 0 0 0 CANDACE SUE 1.00 X 0 0 0 MICHAEL MANDELL 1.00 X 0 0 0 PATRICK MORTIMER 1.00 X 0 0 0 ANTHONY FEDOROV 1.00 X 0 0 0 THOMAS TOBIN 1.00 X 0 0 0 JOHN SJ BROOKS MD 1.00 X 0 0 0 STACEY BREIDINGER 1.00 X X 0 0 0 LISA CROCKER 1.00 X 0 0 0 GARY TOMEI ESQ 1.00 X X 0 0 0 PATRICIA THORNTON 8.00 X X 0 0 0 MARK THORNTON MD PhD 4.00 X X 0 0 0 MATTHEW ALSANTE 40.00 X 107589 0 0 107589 1 false false false REGISTRY PARTNERS 2966 SOUTH CHURCH ST PMB 293 BURLINGTON NC 27215 PATIENT REGISTRY 161907 POWERED BY PROFESSIONALS INC 1375 BROADWAY THIRD FLOOR NEW YORK NY 10018 ANNUAL GALA 147348 2 1019984 345499 18991 1365483 0 46568 46568 0 0 0 186221 192240 -6019 -6019 -6019 647465 1019984 647465 0 0 0 REIMB EXPS & MISC. 900099 25129 25129 25129 1431161 19110 46568 548321 548321 0 50000 50000 0 107589 91451 5379 10759 0 229751 55140 71223 103388 6703 2882 1475 2346 57048 24531 12550 19967 26751 11503 5885 9363 0 0 6780 6780 60000 60000 147348 147348 11642 11642 2898 2898 3956 3956 5655 600 4385 670 15202 718 6023 8461 0 20809 20809 17984 11381 2323 4280 0 9097 7038 1148 911 0 0 4436 4436 5271 5271 Printing and Publications 14936 5607 639 8690 Postage and Shipping 9565 3359 2597 3609 PATIENT REGISTRY 184936 184936 Marketing 7027 2564 4463 BANK & CREDIT CARD CHARGES 6874 6874 36839 10403 23906 2530 1597418 1070434 196243 330741 157814 78211 1040316 465794 21717 9647 0 0 0 0 0 43789 27861 50340 26659 8848 23681 754449 594571 799074 0 0 1575 3916 2016438 2014825 36025 43533 190821 14400 17523 50425 251877 X 1546202 1285237 419811 477711 1966013 1762948 2016438 2014825 X -166257 -36808 X false true true X false false X 1032817 1079610 996345 1365250 1365483 5839505 0 0 0 0 1032817 1079610 996345 1365250 1365483 5839505 0 0 5839505 49761 44637 35190 36965 40549 207102 0 49761 44637 35190 36965 40549 207102 0 522 15187 38 628 25129 41504 1083100 1139434 1031573 1402843 1431161 6088111 0.95920 0.94930 0.03400 0.03480 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false 101 65504 65605 1004829 1070434 182043 45511 false 182043 182043 273065 65605 65605 45511 45511 68267 101 101 38661 18329 20332 11679 8330 3349 23681 799074 Salary payable 13887 PAYROLL TAX PAYABLE 1035 Credit card payable - Capital One 1853 Benefits payable 748 17523 1431161 1597418 -166257 -36808 -36808 -203065 1437180 6019 6019 1431161 1431161 1640245 42827 42827 1597418 1597418 Part XIII, Line 2d Part XIII, Line 2d: Other expenses and losses per audited F/S Realized gains & losses $6019 Unrealized gains & losses $36808 Part XII, Line 2d Part XII, Line 2d: Other revenue amounts included in F/S but not included on form 990 Realized gains & losses $6019 Part XI, Line 8 Part XI, Line 8: Other Changes in Net Assets or Fund Balances UNREALIZED GAINS & LOSSES $ -36808 true CANADA 0 0 50000 50000 50000 CANADA RESEARCH 50000 1 false false false false false false Grantmaker's Description of How Grants are Used in Foreign Country Applicants for SFA grants must submit an application outlining their proposed research project along with a detailed budget that demonstrates how the award money is to be used. Applicants are made aware that a requirement of the acceptance of grant money is that a final report will be submitted to the SFA at the end of the one-year grant period. The final report is due to the SFA by July 31 of the year after the award is made. Final reports are to contain information on how the reserach progressed and it must be signed by both the primary investigator as well as their department chair. X X X false POWERED BY PROF 1375 BROADWAY NEW YORK NY 10018 ANNUAL GALA false 1159795 147348 1012447 1159795 147348 1012447 WI WA VA SC PA OR NY NJ NC MN MI MD MA KY IL GA FL CT CA GALA 1255781 922518 333263 95986 133728 19349 121291 CA4ACURE GALA 107764 39209 68555 14552 15220 23402 1555 132138 6 303904 58257 245647 21564 3667 65013 1667449 1019984 647465 132102 148948 46418 1555 318442 647465 true UPCIUMPC CANCER CENTERS UPMC CANCER PAVILLION STE 1B PITTSBURGH PA 15232 250965591 501(C)3 23321 0 RESERACH UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE SALT LAKE UTAH UT 84112 876000525 501(C)3 50000 0 RESEARCH MEMORIAL SLOAN-KETTERING CANC 633 THIRD AVENUE 28TH FLOOR NEW YORK NY 10017 131924236 501(C)3 50000 0 RESEARCH MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD UNIT 202 HOUSTON TX 77030 746001118 501(C)3 50000 0 RESEARCH JOHNS HOPKINS UNIVERSITY 1101 E 33RD STREET SUITE B MD 21218 520595110 501(C)3 50000 0 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501(C)3 50000 0 RESEARCH CONQUER CANCER FOUNDATION 2318 MILL ROAD SUITE 800 ALEXANDRIA VA 22314 311667995 501(C)3 167500 0 RESEARCH CASE WESTERN RESERVE UNIVERSI 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)3 50000 0 RESEARCH ASCO CANCER FOUNDATION 2318 MILL ROAD SUITE 800 ALEXANDRIA VA 22314 311667995 501(C)3 57500 0 RESEARCH 9 0 Grantmaker's Description of How Grants are Used Applicants for SFA grants must submit an application outlining their proposed research project along with a detailed budget that demonstrates how the award money is to be used. Applicants are made aware that a requirement of the acceptance of grant money is that a final report will be submitted to the SFA at the end of the one-year grant period. The final report is due to the SFA by July 31 of the year after the award is made. Final reports are to contain information on how the research progressed and it must be signed by both the primary investigator as well as their department chair. Form 990, Part VI, Line 19 Form 990, Part VI, Line 19: Other Organization Documents Publicly Available Governing documents, conflict of interest policy are available upon request, financial statements are available on the website as well as on request. Form 990, Part VI, Line 15b Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees The Board of Directors has an appointed compensation committee that reviews and approves the salary of the executive director on an annual basis using current economic comparative data. Form 990, Part VI, Line 12c Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts At least once a year, each person acting on behalf of the Sarcoma Foundation of America, Inc., shall execute and submit a statement to the president and vice president disclosing all material facts concerning any actual or potential conflict of interest or confirming that there are no such conflicts to be disclosed. Form 990, Part VI, Line 11 Form 990, Part VI, Line 11: Form 990 Review Process The Bookkeeper, treasurer and executive director (officer) review the 990 based on the financial records, policies and programs of the organization. Form 990, Part VI, Line 2 Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et MARK THORNTON (PRESIDENT) AND PATRICIA THORNTON (TREASURER) ARE HUSBAND AND WIFE. Client Note 1 - Will work to effect, though congressional action. changes to the FDA regulatory process which would consistently and predictably utilize progression free survival as the primary endpoint for and basis full approval of, new drugs for rare cancers.